Scarica l'app Stockscreener
20.58
0.72%
-0.15
Dopo l'orario di chiusura:
20.00
-0.58
-2.82%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$20.73
Aprire:
$20.76
Volume 24 ore:
320.96K
Relative Volume:
1.53
Capitalizzazione di mercato:
$365.97M
Reddito:
$114.73M
Utile/perdita netta:
$-140.94M
Rapporto P/E:
-7.4565
EPS:
-2.76
Flusso di cassa netto:
$-126.18M
1 W Prestazione:
+5.21%
1M Prestazione:
+15.55%
6M Prestazione:
+17.26%
1 anno Prestazione:
-63.61%
Intervallo 1D:
$20.39
$21.25
Intervallo di 1 settimana:
$18.44
$21.25
Portata 52W:
$5.85
$72.60
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Confronta OM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
20.58 | 365.97M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Outset Medical Inc (OM) Shares Down 5.6% on Jun 17 - GuruFocus
Transcript : Outset Medical, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 11 - marketscreener.com
Outset Medical at Goldman Sachs Conference: Strategic Focus on Acute and Home Dialysis - Investing.com Canada
Outset Medical appoints Renee Gaeta as CFO - MedTech Dive
Outset Medical Inc (OM) Trading 3.49% Higher on Jun 5 - GuruFocus
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors Who Suffered Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | OM Stock News - GuruFocus
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
BTIG maintains buy rating on Outset Medical stock after CFO change By Investing.com - Investing.com South Africa
Outset Medical Appoints Renee Gaeta as Chief Financial Officer | - GuruFocus
TD Cowen Adjusts Price Target on Outset Medical to $25 From $15, Maintains Buy Rating - MarketScreener
BTIG maintains buy rating on Outset Medical stock after CFO change - Investing.com India
BTIG Reiterates Buy Rating on Outset Medical Inc. (OM) - StreetInsider
Outset Medical names Renee Gaeta as new CFO By Investing.com - Investing.com South Africa
Outset Medical Appoints Renee Gaeta As Chief Financial Officer - marketscreener.com
Outset Medical names Renee Gaeta as new CFO - Investing.com
Outset Medical Names Renee Gaeta as CFO - marketscreener.com
Outset Medical Appoints Renee Gaeta as CFO - TipRanks
Outset Medical Appoints Renee Gaeta as Chief Financial Officer | OM Stock News - GuruFocus
Outset Medical (OM) Welcomes Renee Gaeta as New CFO | OM Stock N - GuruFocus
Outset Medical Appoints Renee Gaeta as Chief Financial Officer - The Manila Times
Outset Medical, Inc. Announces Executive Changes - marketscreener.com
Outset Medical, Inc. Announces CFO Changes - MarketScreener
Former Shockwave CFO joins Outset Medical in the same role - MassDevice
Bronstein, Gewirtz & Grossman, LLC Notifies Outset Medical, Inc. (OM) Investors of Class Action and Encourages Investors to Contact the Firm - ACCESS Newswire
Outset Medical Inc (OM) Stock Price Down 8.67% on May 29 - GuruFocus
Smart Dialysis System Market Growth Potential is Booming Now: Outset Medical, Mesa Virginia Tech - openPR.com
Outset Medical (NASDAQ:OM) Receives “Sector Perform” Rating from Royal Bank of Canada - Defense World
Outset Medical (NASDAQ:OM) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says - Defense World
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation - Investing.com Australia
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation By Investing.com - Investing.com India
Outset Medical shares rise on RBC price target boost By Investing.com - Investing.com South Africa
OM: Analyst Shagun Singh Raises Price Target for Outset Medical - GuruFocus
Outset Medical shares rise on RBC price target boost - Investing.com
Outset Medical Inc. (OM) PT Raised to $21 at RBC Capital - StreetInsider
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating - marketscreener.com
Outset Medical Inc (OM) Shares Gap Down to $18.845 on May 20 - GuruFocus
RBC Capital Raises Price Target for Outset Medical (OM) to $21 | OM Stock News - GuruFocus
Outset Medical Inc (OM) Shares Down 2.3% on May 16 - GuruFocus
Outset Medical appoints Kevin O’Boyle to its Board - Medical Buyer
Outset Medical adds healthcare veteran to board By Investing.com - Investing.com Nigeria
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Outset Medical Inc Azioni (OM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nash Marc | SVP Operations and R&D |
May 15 '25 |
Sale |
17.82 |
252 |
4,491 |
13,465 |
| Brottem John L. | General Counsel |
May 15 '25 |
Sale |
17.82 |
396 |
7,057 |
11,273 |
| Ahmed Nabeel | Chief Financial Officer |
May 15 '25 |
Sale |
17.81 |
584 |
10,401 |
16,096 |
0.54%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):